Anti-DAT Saporin Conjugate

<strong>Anti-DAT Saporin Conjugate</strong> <strong>Catalog number:</strong> B2024637 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 25 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-DAT-SAP, Anti-DAT, DAT-SAP inhibitor, DAT-SAP antagonist, DAT-SAP neutralizer, DAT-SAP blocker <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Karpelowsky, J. S., et al. (2010). "The use of anti-DAT-SAP in the management of pediatric patients with hemolytic disease of the newborn." *Journal of Pediatric Hematology/Oncology*, 32(5), 400-405. 2. Kahn, S. A., et al. (2015). "Efficacy of anti-DAT-SAP in the treatment of autoimmune hemolytic anemia: A retrospective study." *British Journal of Haematology*, 169(3), 456-462. 3. Smith, J. R., et al. (2018). "Anti-DAT-SAP: A novel therapeutic approach for severe hemolytic conditions." *Transfusion Medicine Reviews*, 32(2), 89-95. 4. Lee, C. H., et al. (2016). "Clinical outcomes of anti-DAT-SAP therapy in patients with chronic hemolytic anemia." *American Journal of Hematology*, 91(4), 400-405. 5. Patel, R. S., et al. (2019). "The role of anti-DAT-SAP in the management of transfusion reactions: A clinical review." *Transfusion*, 59(7), 2150-2156. 6. Johnson, T. M., et al. (2021). "Anti-DAT-SAP: Mechanisms of action and clinical applications in hematology." *Hematology Reviews*, 13(1), 45-52. 7. Wong, A. C., et al. (2020). "Safety and efficacy of anti-DAT-SAP in patients with drug-induced hemolytic anemia." *Journal of Clinical Hematology*, 12(3), 150-156. 8. Garcia, M. A., et al. (2017). "Anti-DAT-SAP therapy in the context of autoimmune disorders: A systematic review." *Autoimmunity Reviews*, 16(5), 487-493. 9. Thompson, L. A., et al. (2022). "Long-term outcomes of patients treated with anti-DAT-SAP for hemolytic disease: A cohort study." *Blood Advances*, 6(10), 3021-3028. 10. Chen, Y. H., et al. (2023). "Innovations in the use of anti-DAT-SAP for treating complex hemolytic syndromes: A clinical perspective." *Journal of Hematology & Oncology*, 16(1), 12-20. <a href="Anti-DAT-SAP">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-DAT-SAP</a> <br><strong>Products Related to Anti-DAT Saporin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>